Erscheinungsjahr
Format
Lizenz
Sprache
-
Comparing Sequencing of Abiraterone and Enzalutamide in Men With Metastatic Castration‐Resistant Prostate Cancer: A Retrospective Study
Wiley | 2017|Schlagwörter: metastatic castration‐resistant prostate cancer -
A European, prospective, observational study of enzalutamide in patients with metastatic castration‐resistant prostate cancer: PREMISE
Wiley | 2022|Schlagwörter: metastatic castration‐resistant prostate cancer -
To treat or not to treat: is it acceptable to avoid active therapies in advanced prostate cancer today?
Taylor & Francis Verlag | 2021|Schlagwörter: metastatic castration-resistant prostate cancer, non-metastatic castration-resistant prostate cancer -
Earlier use of androgen receptor‐axis‐targeted drugs may improve overall survival in patients with non‐metastatic castration‐resistant prostate cancer
Wiley | 2018|Schlagwörter: metastatic castration‐resistant prostate cancer (mCRPC), non‐metastatic castration‐resistant prostate cancer (nmCRPC) -
Safety and efficacy of 2‐weekly cabazitaxel in metastatic castration‐resistant prostate cancer
Wiley | 2018|Schlagwörter: metastatic castration‐resistant prostate cancer -
An exploratory first‐in‐man study to investigate the pharmacokinetics and safety of liposomal dexamethasone at a 2‐ and 1‐week interval in patients with metastatic castration resistant prostate cancer
Freier ZugriffWiley | 2021|Schlagwörter: metastatic castration resistant prostate cancer -
Oral Mucositis with Abiraterone Acetate: A Therapeutic Dilemma
Freier ZugriffThieme Verlag | 2020|Schlagwörter: metastatic castration-resistant prostate cancer -
Prognostic value of an inflammatory index for patients with metastatic castration‐resistant prostate cancer
Wiley | 2020|Schlagwörter: metastatic castration‐resistant prostate cancer -
Enzalutamide in European and North American men participating in the AFFIRM trial
Wiley | 2015|Schlagwörter: metastatic castration‐resistant prostate cancer -
Enzalutamide in castration‐resistant prostate cancer patients with visceral disease in the liver and/or lung: Outcomes from the randomized controlled phase 3 AFFIRM trial
Wiley | 2017|Schlagwörter: metastatic castration‐resistant prostate cancer -
Useful predictors of progression‐free survival for Japanese patients with LATITUDE‐high‐risk metastatic castration‐sensitive prostate cancer who received upfront abiraterone acetate
Wiley | 2022|Schlagwörter: metastatic castration‐resistant prostate cancer -
Beyond cabazitaxel: Late line treatments in metastatic castration resistant prostate cancer: A retrospective multicentre analysis
Wiley | 2022|Schlagwörter: metastatic castration‐resistant prostate cancer -
Castration-resistant prostate cancer patients who had poor response on first androgen deprivation therapy would obtain certain clinical benefit from early docetaxel administration
Online Contents | 2019|Schlagwörter: Metastatic castration-resistant prostate cancer -
Targeting DNA repair with combination veliparib (ABT-888) and temozolomide in patients with metastatic castration-resistant prostate cancer
Online Contents | 2014|Schlagwörter: Metastatic castration-resistant prostate cancer -
Quo vadis: Advanced prostate cancer—clinical care and clinical research in the era of multiple androgen receptor‐directed therapies
Wiley | 2015|Schlagwörter: metastatic castration‐resistant prostate cancer -
Phase II study of Cilengitide (EMD 121974, NSC 707544) in patients with non-metastatic castration resistant prostate cancer, NCI-6735. A study by the DOD/PCF prostate cancer clinical trials consortium
Online Contents | 2010|Schlagwörter: Non-metastatic castration resistant prostate cancer -
Risk of development of visceral metastases subsequent to abiraterone vs placebo: An analysis of mode of radiographic progression in COU‐AA‐302
Wiley | 2019|Schlagwörter: metastatic castration‐resistant prostate cancer -
Treatment evolution for metastatic castration‐resistant prostate cancer with recent introduction of novel agents: retrospective analysis of real‐world data
Freier ZugriffWiley | 2016|Schlagwörter: metastatic castration‐resistant prostate cancer -
Contemporary experience with ketoconazole in patients with metastatic castration‐resistant prostate cancer: Clinical factors associated with PSA response and disease progression
Wiley | 2012|Schlagwörter: metastatic castration‐resistant prostate cancer -
Cost per median overall survival month associated with abiraterone acetate and enzalutamide for treatment of patients with metastatic castration-resistant prostate cancer
Freier ZugriffTaylor & Francis Verlag | 2016|Schlagwörter: Metastatic castration-resistant prostate cancer
Meine Suche schicken an (beta)
Schicken Sie ihre Suchanfrage (Suchterm ohne Filter) an andere Datenbanken, Portale und Kataloge, um ggf. weitere interessante Treffer zu finden:
Dimensions ist eine Datenbank für Abstracts und Zitate, die Informationen zu Forschungsförderungen mit daraus resultierenden Veröffentlichungen, Studien und Patenten verknüpft.
Im TIB AV-Portal können audiovisuelle Medien aus Wissenschaft und Lehre recherchiert und eigene wissenschaftliche Videos publiziert werden.
Im FID move kann nach fachspezifischer Literatur, Forschungsdaten und weitere Informationen aus der Mobilitäts- und Verkehrsforschung gesucht werden.
Der Open Research Knowledge Graph liefert strukturiert beschriebene Forschungsinhalte und macht diese vergleichbar.
Frei zugänglicher Ausschnitt der Verbunddatenbank K10plus des GBV und des SWB mit für die Fernleihe und Direktlieferdienste relevanten Materialien.